- Report
- April 2023
- 125 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 80 Pages
United States
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 80 Pages
United Kingdom
From €4348EUR$4,750USD£3,695GBP
- Training
- November 2023
- 2 Days
Global
€3376EUR$3,688USD£2,869GBP
- Report
- September 2018
- 112 Pages
Global
From €2517EUR$2,750USD£2,139GBP
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Report
- June 2023
- 390 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Book
- October 2022
- 816 Pages
- Book
- September 2021
- 576 Pages
- Book
- April 2021
- 6032 Pages
€4059EUR$4,589USD£3,333GBP
- Book
- October 2019
- 472 Pages
- Book
- September 2019
- 272 Pages
- Book
- June 2019
- 1168 Pages
- Book
- February 2019
- 512 Pages
- Book
- September 2018
- 576 Pages
- Book
- August 2018
- 816 Pages
- Book
- March 2018
- 368 Pages

The Drug Substance market is a key component of the Drug Discovery process. It involves the production of active pharmaceutical ingredients (APIs) for use in the development of new drugs. Drug Substance manufacturers are responsible for producing APIs in a variety of forms, such as powders, liquids, and tablets. The APIs are then used in the formulation of drug products, which are then tested in clinical trials.
The Drug Substance market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the APIs. The market is also highly competitive, with many companies vying for market share. Companies must also adhere to strict environmental regulations, as well as ethical standards, in order to remain competitive.
Some of the major players in the Drug Substance market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more